Clinical High Risk for Developing Psychosis: Clinical Trials

2 trials for Clinical High Risk for Developing Psychosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Not yet recruiting 1

Follow Clinical High Risk for Developing Psychosis: new trials by email Literature Review of Clinical High Risk for Developing Psychosis trials Research Report on Clinical High Risk for Developing Psychosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stratification and Treatment in Early Psychosis Study - PROMOTE
Cannabidiol (CBD), Placebo - Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis
Phase 3Not yet recruitingUniversity of Oxford5862026-12-012026-10-08
Stepped Care for Youth at Risk of Psychosis
Supportive therapy and CBT - Clinical High Risk for Developing Psychosis
Not applicableCompletedUniversity of Calgary612021-09-012026-09-17

Narrower conditions

Psychotic Disorders (1)

Broader conditions

Mental Disorders (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Interventions

Cannabidiol (1)  ·  Palliative Care (1)

Sponsors

University of Calgary (1)  ·  University of Oxford (1)

Countries

Canada (2)  ·  Austria (1)  ·  Finland (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Jean M Addington, PhD (1)  ·  Philip McGuire, PhD, MD (1)

Results publications

PMID 42827309